Odisha: IIT Bhubaneswar signs agreement for Novel TB vaccine technology

Odisha: IIT Bhubaneswar Signs Agreement for Novel TB Vaccine Technology Odisha: IIT Bhubaneswar Signs Agreement for Novel TB Vaccine Technology Bhubaneswar, November 24, 2025 – In a significant advancement for indigenous tuberculosis (TB) vaccine research, the Indian Institute of Technology (IIT) Bhubaneswar, the Institute of Life Sciences (ILS), and the National Research Development Corporation (NRDC)…

IIT Bhubaneswar signs agreement for TB vaccine

IIT Bhubaneswar Signs Agreement for TB Vaccine IIT Bhubaneswar Signs Agreement for TB Vaccine Bhubaneswar: In a significant development for tuberculosis (TB) vaccine research, IIT Bhubaneswar has entered into a Quadripartite License Agreement with the Institute of Life Sciences (ILS), the National Research Development Corporation (NRDC), and TechInvention Lifecare Limited. This agreement marks a pivotal…

IIT-BBS & ILS hand new TB vaccine tech to TechInvention

IIT-BBS & ILS Hand New TB Vaccine Tech to TechInvention IIT-BBS & ILS Hand New TB Vaccine Tech to TechInvention In a significant advancement in public health, the Indian Institute of Technology (IIT) Bhubaneswar and the Institute of Life Sciences (ILS) have collaborated with the National Research Development Corporation (NRDC) to transfer a novel tuberculosis…

IIT Bhubaneswar, ILS transfer novel TB vaccine technology to TechInvention Lifecare; NRDC facilitates licensing

IIT Bhubaneswar and ILS Transfer Novel TB Vaccine Technology to TechInvention Lifecare IIT Bhubaneswar and ILS Transfer Novel TB Vaccine Technology to TechInvention Lifecare Published on: 25 Nov 2025 Introduction In a significant advancement in the fight against tuberculosis (TB), the Indian Institute of Technology (IIT) Bhubaneswar and the Institute of Life Sciences (ILS), Bhubaneswar,…

1 7 8 9 10 11 18